PLATANIA, CHIARA BIANCA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.884
EU - Europa 1.017
AS - Asia 622
AF - Africa 207
SA - Sud America 134
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 3.871
Nazione #
US - Stati Uniti d'America 1.834
IT - Italia 507
SG - Singapore 385
IE - Irlanda 205
CN - Cina 174
BR - Brasile 120
CI - Costa d'Avorio 117
UA - Ucraina 85
SN - Senegal 71
DE - Germania 66
CA - Canada 38
RU - Federazione Russa 38
GB - Regno Unito 24
SE - Svezia 23
IN - India 18
FR - Francia 12
VN - Vietnam 12
FI - Finlandia 10
MX - Messico 10
BE - Belgio 8
NG - Nigeria 8
NL - Olanda 8
ES - Italia 6
CH - Svizzera 5
AR - Argentina 4
AT - Austria 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
EU - Europa 4
JP - Giappone 4
KR - Corea 4
MA - Marocco 4
PL - Polonia 4
TR - Turchia 4
ZA - Sudafrica 4
AU - Australia 3
BD - Bangladesh 3
GR - Grecia 3
HK - Hong Kong 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CO - Colombia 2
IQ - Iraq 2
NP - Nepal 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
GH - Ghana 1
GT - Guatemala 1
ID - Indonesia 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
OM - Oman 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 3.871
Città #
Santa Clara 432
Chandler 325
Singapore 231
Dublin 205
Catania 170
Chicago 157
Abidjan 117
Jacksonville 94
Houston 85
Boardman 83
Dakar 71
Cambridge 49
Lawrence 48
Andover 44
Ashburn 44
Civitanova Marche 36
Toronto 27
Wilmington 27
Des Moines 25
Nanjing 23
Bremen 22
Rome 17
Falls Church 16
Council Bluffs 14
Messina 14
Aci Catena 13
Palermo 13
Seattle 13
Milan 11
Redwood City 11
Boydton 10
Changsha 10
Dong Ket 10
Hebei 10
Ottawa 10
Saint Petersburg 10
Shenyang 10
San Mateo 9
Abuja 8
Grafing 8
Redmond 8
Jiaxing 7
Mumbai 7
Munich 7
Nanchang 7
Naples 7
Rio de Janeiro 7
Rosolini 7
San Gregorio di Catania 7
São Paulo 7
Belo Horizonte 6
Dearborn 6
Guangzhou 6
Los Angeles 6
Mercogliano 6
Pozzallo 6
Shanghai 6
Brussels 5
Moscow 5
Washington 5
Baranzate 4
Cagliari 4
Helsinki 4
Jinan 4
Lappeenranta 4
Manchester 4
Ningbo 4
Novara 4
Pune 4
Stockholm 4
Tianjin 4
Turin 4
Vicenza 4
Zhengzhou 4
Beijing 3
Brasília 3
Caltanissetta 3
Casaleone 3
Curitiba 3
Enna 3
Garza García 3
Hyderabad 3
Lecce 3
Liberty Lake 3
Manaus 3
Milltown 3
Modena 3
Paternò 3
Sesto Fiorentino 3
Solna 3
Sumaré 3
São Bernardo do Campo 3
Tappahannock 3
Tokyo 3
Warsaw 3
Aci Sant'Antonio 2
Bangalore 2
Baoding 2
Bernareggio 2
Bronte 2
Totale 2.789
Nome #
Current drug treatments targeting dopamine D3 receptor 167
Antioxidant and osmoprotecting activity of taurine in dry eye models 111
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 104
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 99
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 98
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 96
Caffeine Protects Against Retinal Inflammation 93
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 92
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 90
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 88
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 85
P2X7 receptor antagonism: implications in diabetic retinopathy 82
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 81
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 79
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease 77
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 75
Drug delivery of synthetic antisense “Bioconjugates” for anticancer therapy DNA. 73
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 72
Controversies in Glaucoma: Current Medical Treatment and Drug Development 71
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 70
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 68
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 68
DRUG DELIVERY OF SYNTHETIC ANTISENSE-DNA "BIOCONJUGATES" FOR ANTICANCER THERAPY 67
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 67
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 65
Novel therapeutics in glaucoma management 65
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 64
Retinal protection and distribution of curcumin in vitro and in vivo 64
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 63
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 63
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 62
Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor 61
Drug Delivery of Synthetic Antisense-DNA “bioconjugates” for Anticancer Therapy 59
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 58
Ocular allergy 58
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 58
Ocular pharmacological profile of hydrocortisone in dry eye disease 58
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 56
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 56
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 56
Do extracellular RNAs provide insight into uveal melanoma biology? 55
Molecular basis of alcohol intake: role of D3 dopaminergic receptor 53
Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR) 53
MicroRNA target prediction in glaucoma 52
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 52
Novel heme oxygenase-1 (Ho-1) inducers based on dimethyl fumarate structure 51
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 51
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery 50
Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration 49
Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose 47
Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors 47
In-Silico Characterization of von Willebrand Factor Bound to FVIII 41
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? 41
Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease 38
The P2X7 receptor as a new pharmacological target for retinal diseases 37
Integrating network pharmacology: The next-generation approach in ocular drug discovery 34
Characterization of protein-protein interfaces through a protein contact network approach 33
Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. 31
Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs 29
Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study 26
Implications of dopamine D3 receptor for glaucoma: in-silico and in-vivo studies 19
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 19
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy 15
Erratum: Homology modeling of dopamine D2 and D3 receptors: Molecular dynamics refinement and docking evaluation (PLoS ONE (2013) 8:1 DOI: 10.1371/annotation/bd61cc74-2a2c-4433-a78d-84fa2310e919) 14
Ocular Allergies 11
The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach 8
α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells 7
Totale 4.002
Categoria #
all - tutte 14.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202034 0 0 0 0 0 0 0 0 0 0 19 15
2020/2021241 15 16 21 3 53 13 34 5 19 15 27 20
2021/2022403 31 45 10 8 52 25 66 23 32 6 19 86
2022/2023939 62 66 18 110 123 122 16 172 176 16 31 27
2023/2024409 32 45 18 21 31 116 7 31 1 3 57 47
2024/20251.557 43 259 84 129 379 246 106 57 134 108 12 0
Totale 4.002